CJC-1295 and MK-677 are both Growth Hormone peptides, but they're studied for different things. In short, CJC-1295 is a growth-hormone-releasing hormone analog studied for GH support, while MK-677 is an orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1. This page compares the two side by side — what each is researched for, how mature the evidence is, and how they're typically used — so you can see where they overlap and where they differ. It's educational information only, not medical advice, and neither is a substitute for a conversation with a licensed professional.
CJC-1295 vs MK-677 at a glance
| CJC-1295 | MK-677 | |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| In short | A growth-hormone-releasing hormone analog studied for GH support. | An orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1. |
| Researched for | Growth hormone release, Body composition, Recovery & sleep | Growth hormone & IGF-1, Sleep, Body composition, Bone density |
| Research status | Some human pharmacology studies; not an approved therapy. | Investigated in human trials; not approved for these uses. |
| Typically stacked with | Ipamorelin | — |
| Key consideration | Affects the endocrine system. Research use only in most regions. | Can increase appetite, water retention and blood sugar. Technically a non-peptide secretagogue. |
How does CJC-1295 work?
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release the body's own growth hormone in a more sustained way, and is often researched together with a ghrelin-type secretagogue for a more pulsatile release pattern.
How does MK-677 work?
MK-677 (ibutamoren) is an orally active, long-acting growth-hormone secretagogue. Although technically a non-peptide, it is grouped with GH peptides because it mimics ghrelin to raise growth hormone and IGF-1 levels.
CJC-1295 vs MK-677: how to choose
Choosing between CJC-1295 and MK-677 really comes down to your specific goal — and it's a decision for you and a licensed professional, not something to settle from a web page. CJC-1295 is most associated with Growth hormone release and Body composition, while MK-677 leans toward Growth hormone & IGF-1 and Sleep. Where they overlap, the practical differences are usually in mechanism and how far the research has actually progressed. Selpho provides no dosing or protocols; if you'd like a research-backed steer for your goals, the free Peptide Advisor is a good starting point.
Frequently asked questions
Both are Growth Hormone peptides. CJC-1295 is a growth-hormone-releasing hormone analog studied for GH support; MK-677 is an orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1. They're most researched for Growth hormone release, Body composition (CJC-1295) and Growth hormone & IGF-1, Sleep (MK-677), respectively.
There's no universal "better" — it depends on your goal, and for most of these compounds robust head-to-head human evidence doesn't exist. The right choice is one made with a licensed professional. Selpho does not rank or prescribe; it offers educational information and a research-backed advisor.
They're in the same category, and combining research compounds is something to approach only with a licensed professional, since interactions and individual context matter. Selpho provides no dosing or protocols.
CJC-1295: Some human pharmacology studies; not an approved therapy. MK-677: Investigated in human trials; not approved for these uses.
Not sure which fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis comparison is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.